Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Paul J. Joudrey, Gavin Bart, Robert K. Brooner, Lawrence Brown, Julie Dickson-Gomez, Adam Gordon, Sarah S. Kawasaki, Jane M. Liebschutz, Edward Nunes, Dennis McCarty, Robert P. Schwartz, José Szapocnik, Madhukar Trivedi, Judith I. Tsui, Arthur Williams, Li-Tzy Wu & David A. Fiellin. (2021) Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Clinical Trials Network Task Force report. Substance Abuse 42:3, pages 245-254.
Read now
Read now
Miriam Adelson, Dinita Smith & Einat Peles. (2021) Trend differences over 20 years between two methadone maintenance clinics, one with and one without cannabis legalization. Journal of Addictive Diseases 39:2, pages 226-233.
Read now
Read now
Michael Fendrich & Thomas P. LeBel. (2019) Implementing access to medication assisted treatment in a drug treatment court: Correlates, consequences, and obstacles. Journal of Offender Rehabilitation 58:3, pages 178-198.
Read now
Read now
Vesna Mijatović, Isidora Samojlik, Stojan Petković, Saša Vukmirović, Arsen Uvelin & Aleksandra Dickov. (2017) Cardiovascular effects of methadone and concomitant use of diazepam during methadone maintenance treatment induction: low concentration risk. Expert Opinion on Drug Safety 16:12, pages 1323-1328.
Read now
Read now
Erin M. Kerrison. (2017) An historical review of racial bias in prison-based substance abuse treatment design. Journal of Offender Rehabilitation 56:8, pages 567-592.
Read now
Read now
Eduardo R. Butelman & Mary Jeanne Kreek. (2017) Medications for substance use disorders (SUD): emerging approaches. Expert Opinion on Emerging Drugs 22:4, pages 301-315.
Read now
Read now
Articles from other publishers (23)
Ewa Galaj, Guo-Hua Bi, Benjamin Klein, Briana Hempel, Anver Basha Shaik, Emma S. Gogarnoiu, Jacob Friedman, Jenny Lam, Rana Rais, John F. Reed, Shelley H. Bloom, Tracy L. Swanson, Jennifer L. Schmachtenberg, Amy J. Eshleman, Aaron Janowsky, Zheng-Xiong Xi & Amy Hauck Newman. (2022) A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder. Neuropsychopharmacology 47:13, pages 2309-2318.
Crossref
Crossref
Zhi-Bing You, Eliot L. Gardner, Ewa Galaj, Allamar R. Moore, Tristram Buck, Chloe J. Jordan, Bree A. Humburg, Guo-Hua Bi, Zheng-Xiong Xi & Lorenzo Leggio. (2022) Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches. Molecular Psychiatry 27:4, pages 2171-2181.
Crossref
Crossref
Chiemeka Ezie, Ryan Badolato, Mary Rockas, Rayek Nafiz, Brian Sands, Adam Wolkin & Pantea Farahmand. (2022) COVID 19 and the Opioid Epidemic: An Analysis of Clinical Outcomes During COVID 19. Substance Abuse: Research and Treatment 16, pages 117822182210855.
Crossref
Crossref
Juan J. Ruíz Ruíz, José M. Martinez Delgado & Nuria García-Marchena. (2021) Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders. Harm Reduction Journal 18:1.
Crossref
Crossref
David Frank. (2021) A chance to do it better: Methadone maintenance treatment in the age of Covid-19. Journal of Substance Abuse Treatment 123, pages 108246.
Crossref
Crossref
Yngvild Olsen & Angela Mason. 2021. Treating Opioid Use Disorder in General Medical Settings. Treating Opioid Use Disorder in General Medical Settings
173
188
.
Maria Carmen Blanco-Gandía, Sandra Montagud-Romero & Marta Rodríguez-Arias. 2020. Opioids - From Analgesic Use to Addiction. Opioids - From Analgesic Use to Addiction.
Einat Peles, Orna Levran, Matthew Randesi, Jurg Ott, Mary Jeanne Kreek & Miriam Adelson. (2019) Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction. Journal of Addiction Medicine 13:6, pages 430-435.
Crossref
Crossref
Chloe J. Jordan, Bree Humburg, Myra Rice, Guo-Hua Bi, Zhi-Bing You, Anver Basha Shaik, Jianjing Cao, Alessandro Bonifazi, Alexandra Gadiano, Rana Rais, Barbara Slusher, Amy Hauck Newman & Zheng-Xiong Xi. (2019) The highly selective dopamine D R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents. Neuropharmacology 158, pages 107597.
Crossref
Crossref
Randal A. Serafini & Venetia Zachariou. (2019) Opioid–galanin receptor heteromers differentiate the dopaminergic effects of morphine and methadone. Journal of Clinical Investigation 129:7, pages 2653-2654.
Crossref
Crossref
Yang Lv, Rong-rong Hu, Manyi Jing, Tai-yun Zhao, Ning Wu, Rui Song, Jin Li & Gang Hu. (2018) Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice. Acta Pharmacologica Sinica 40:5, pages 583-588.
Crossref
Crossref
Keith G. Heinzerling. 2019. The Assessment and Treatment of Addiction. The Assessment and Treatment of Addiction
137
156
.
Jorge Manzanares, David Cabañero, Nagore Puente, María S. García-Gutiérrez, Pedro Grandes & Rafael Maldonado. (2018) Role of the endocannabinoid system in drug addiction. Biochemical Pharmacology 157, pages 108-121.
Crossref
Crossref
M. Carmen Blanco-Gandía & Marta Rodríguez-Arias. (2018) Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years. European Journal of Pharmacology 836, pages 89-101.
Crossref
Crossref
Beth WieseAdrianne R. Wilson-Poe. (2018) Emerging Evidence for Cannabis' Role in Opioid Use Disorder. Cannabis and Cannabinoid Research 3:1, pages 179-189.
Crossref
Crossref
Shannon Gwin Mitchell, Laura B. Monico, Elizabeth Lertch, Sharon M. Kelly, Jan Gryczynski, Jerome H. Jaffe, Kevin E. O’Grady & Robert P. Schwartz. (2018) Counseling Staff’s Views of Patient-Centered Methadone Treatment: Changing Program Rules and Staff Roles. The Journal of Behavioral Health Services & Research 45:3, pages 506-515.
Crossref
Crossref
Devesh Vashishtha, Maria Luisa Mittal & Daniel Werb. (2017) The North American opioid epidemic: current challenges and a call for treatment as prevention. Harm Reduction Journal 14:1.
Crossref
Crossref
Zhi-Bing You, Jun-Tao Gao, Guo-Hua Bi, Yi He, Comfort Boateng, Jianjing Cao, Eliot L. Gardner, Amy Hauck Newman & Zheng-Xiong Xi. (2017) The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats. Neuropharmacology 126, pages 190-199.
Crossref
Crossref
Giovanni C Santoro, Joseph Carrion, Krishna Patel, Crystal Vilchez, Jennifer Veith, Jonathan D Brodie & Stephen L Dewey. (2017) Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement. Neuropsychopharmacology 42:9, pages 1841-1849.
Crossref
Crossref
Maximilian Gahr, Jonas Eller, Maurice Cabanis, Christoph Hiemke, Roland W. Freudenmann, Bernhard J. Connemann, Dirk Lang & Carlos Schönfeldt-Lecuona. (2017) Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians. Journal of Substance Abuse Treatment 74, pages 7-15.
Crossref
Crossref
Orly Sarid, Richard Isralowitz, Mor Yehudai & Alexander Reznik. (2016) Suicidal Ideation Among Heroin-Abusing Mothers in Methadone Maintenance Treatment. Crisis 37:6, pages 461-464.
Crossref
Crossref
E. Salsitz & T. Wiegand. (2015) Pharmacotherapy of Opioid Addiction: ?Putting a Real Face on a False Demon?. Journal of Medical Toxicology 12:1, pages 58-63.
Crossref
Crossref
Zunyou Wu & Roger Detels. (2015) Methadone treatment in primary care. The Lancet HIV 2:10, pages e408-e409.
Crossref
Crossref